NCT02178787View on ClinicalTrials.gov

UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation

CompletedOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Diabetes

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Collaborators (1)

Ornim Medical Ltd.

All Listed Sponsors

collaborator

Ornim Medical Ltd.

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER

NCT02178787 - UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation | Biotech Hunter | Biotech Hunter